source:[1] WellSky and uMed expand home-based clinical trial access nationwide - MobiHealthNews (https://www.mobihealthnews.com/news/wellsky-a ...)[2] Cofactor Genomics Announces Strategic Investment by Labcorp and Ascension Ventures to Fuel Expansion of Its OncoPrism® Immunotherapy Diagnostic Across U.S. Cancer Care Networks - BioSpace (https://www.biospace.com/press-releases/cofac ...)[3] December deal flurry rolls on with Genentech, Caris cancer collab worth up to $1.1B - Fierce Biotech (https://www.fiercebiotech.com/biotech/deal-ma ...)